Andrade, Robert Christopher

Track

Insider profile

Performance

Overall performance
3.6
Performance over holding periods
3.6
30 days 90 days 120 days
Average return 9% 8.2% 15.1%
Success rate 89% 68% 82%
Transactions
5 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Andrade, Robert Christopher's trades of Fennec Pharmaceuticals Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-24 2026-02-19
B Purchase
83,948 -14.1%
495.94
US$2,576,953 		83,948 -14.1% 495.94 US$2,576,953
2026-01-16 2026-01-14
B Purchase
82,623 -6.7%
138.58
US$4,899,178 		82,623 -6.7% 138.58 US$4,899,178
2025-06-04 2025-06-02
B Purchase
42,246 -13.4%
93.02
US$1,356,252 		42,246 -13.4% 93.02 US$1,356,252
2024-11-21 2024-11-18
B Purchase
15,816 +9.5%
2.45
US$38,749 		15,816 +9.5% 2.45 US$38,749
2024-03-29 2024-03-26
S Sale
13,975 -8.6%
10.90
US$152,346 		13,975 -8.6% 10.90 US$152,346
2024-03-29 2024-03-25
S Sale
13,975 -7.9%
11.00
US$153,690 		13,975 -7.9% 11.00 US$153,690
2023-07-05 2023-06-30
S Sale
7,500 -4.1%
8.82
US$66,150 		7,500 -4.1% 8.82 US$66,150
2023-07-05 2023-06-30
S Sale
7,500 -3.9%
8.97
CA$67,275 		7,500 -3.9% 8.97 CA$67,275
2023-07-05 2023-06-30
S Sale
10,000 -5.0%
8.99
US$89,900 		10,000 -5.0% 8.99 US$89,900
2023-07-05 2023-06-30
B Purchase
25,000 +14.1%
2.45
US$61,250 		25,000 +14.1% 2.45 US$61,250
2022-09-22 2022-09-21
S Sale
19,052 -9.7%
8.54
US$162,704 		19,052 -9.7% 8.54 US$162,704